MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0179382
Nucleus Biosciences Private Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2024
₹1.03 Cr
▼ 12% YoY
Net profit · FY 2024
₹75,074
Net margin 0.7%
EBITDA · FY 2024
₹4.06 Lakh
EBITDA margin 4%
Authorised capital
₹15 Lakh
Registered with MCA
Paid-up capital
₹15 Lakh
Issued & subscribed
Satisfied charges
₹62.86 Lakh
No open charges
Company age
15 yrs
Est. 2011
Directors on board
2
As per MCA filings
About Nucleus Biosciences Private Limited
Data last updated:
Nucleus Biosciences Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 05 January 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2011PTC063498. Its GSTIN is 24AADCN6657Q1ZS (Gujarat).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It was formerly known as Walpar Healthcare Private Limited. It is led by directors Himanshu Manubhai Patel and Vishal Parmar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 64 Shri Harikrupa Ind Park Ring Road Hathijan, Ahmedabad, Gujarat, India – 382445.
As per the financials filed for FY 2024, the company reported a revenue of ₹1.03 Cr, a decline of 12% compared to the previous year. For the same year it recorded a net profit of ₹75,074 (net margin 0.7%) and EBITDA of ₹4.06 Lakh (EBITDA margin 4%). Revenue has declined at a compounded annual rate (CAGR) of 11% over three years and 12% over five years.
As per MCA filings, the company has satisfied charges of ₹62.86 Lakh on record.
Nucleus Biosciences Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0179382). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website nucleusbio.in.
Company details
CIN U24230GJ2011PTC063498
Registration Number 063498
Incorporation Date 05 January 2011
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0179382
Recognitions & Rankings of Nucleus Biosciences
Contact details
Nucleus Biosciences Private Limited's registered office is in Ahmedabad, Gujarat. Its website is nucleusbio.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address64 Shri Harikrupa Ind Park Ring Road Hathijan, Ahmedabad, Gujarat, India – 382445
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Nucleus Biosciences Private Limited, buy the company report.
Comprehensive company report
Nucleus Biosciences Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Nucleus Biosciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Nucleus Biosciences Private Limited, buy the company report.
Financials of Nucleus Biosciences Private Limited
FY 2025 filings availableNucleus Biosciences Private Limited reported revenue of ₹1.03 Cr (down 12% YoY) for FY 2024.
Revenue · FY 2024
₹1.03 Cr ▼ 12%
Net profit · FY 2024
₹75,074 margin 0.7%
EBITDA · FY 2024
₹4.06 Lakh margin 4%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 12%
3 years · compounded
▼ 11%
5 years · compounded
▼ 12%
EBITDA CAGR growth
1 year
▼ 31%
3 years · compounded
▼ 34%
5 years · compounded
▼ 25%
Revenue has declined at a compounded annual rate (CAGR) of 12% over five years, including a 12% fall in the latest year. EBITDA fell 31% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹4.06 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹75,074 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Nucleus Biosciences Private Limited, buy the company report.
Board of directors of Nucleus Biosciences Private Limited
Nucleus Biosciences has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Himanshu Manubhai Patel Also directs: Tactus Nutrasciences LLP, Tactus Lifesciences LLP | Director | 05 Jan 2011 | 15 Years 9 Months | Current |
| Vishal Parmar Also directs: Tactus Nutrasciences LLP, Tactus Lifesciences LLP | Director | 05 Jan 2011 | 15 Years 9 Months | Current |
Auditor
Nucleus Biosciences Private Limited is audited by C. K. DAMANI AND ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| C. K. DAMANI AND ASSOCIATES | FY 2023 | 102069W |
Shareholding
The shareholding of Nucleus Biosciences Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Nucleus Biosciences Private Limited, buy the company report.
Charges & borrowings
Open charges
None
Satisfied charges
₹62.86 Lakh
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 07 Jun 2013 | 10431604 | Bank of Baroda | ₹62.86 Lakh | Satisfied |
To see the full charge records of Nucleus Biosciences Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Nucleus Biosciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nucleus Biosciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Nucleus Biosciences has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AADCN6657Q1ZS | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Nucleus Biosciences Private Limited, buy the company report.
Recent activity
Nucleus Biosciences Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Kalpesh Pravinchandra Ladhawala ceased to be Director on 25 Feb 2015.
AGM
Nucleus Biosciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Nucleus Biosciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge registered on 07 Jun 2013 via Charge ID 10431604 with Bank Of Baroda was fully satisfied on 24 Jun 2021.
Ceased
Kalpesh Pravinchandra Ladhawala ceased to be Director.
Charges
A charge with Bank Of Baroda amounted to Rs. 62.86 Lakh with Charge ID 10431604 was registered on 07 Jun 2013.
Appointed
Himanshu Manubhai Patel was appointed as Director.
Appointed
Vishal Parmar was appointed as Director.
Incorporation
05 Jan 2011
Nucleus Biosciences Private Limited was registered on 05 Jan 2011 with Roc Ahmedabad & aged 15 years 9 months as per MCA records.
Frequently asked questions
Nucleus Biosciences is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 05 January 2011 (15+ years old) and is registered under CIN U24230GJ2011PTC063498.
Nucleus Biosciences has 2 current directors:
- Himanshu Manubhai Patel - Director
- Vishal Parmar - Director
The latest financial statements of Nucleus Biosciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Nucleus Biosciences is 24AADCN6657Q1ZS, registered in Gujarat.
The CIN (Corporate Identification Number) of Nucleus Biosciences is U24230GJ2011PTC063498. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nucleus Biosciences was incorporated on 05 January 2011, making it 15+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Kalpesh Pravinchandra Ladhawala ceased to be Director on 25 Feb 2015. Himanshu Manubhai Patel was appointed as Director on 05 Jan 2011. Vishal Parmar was appointed as Director on 05 Jan 2011.
Yes, Nucleus Biosciences is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0179382).
Nucleus Biosciences can be reached through the website nucleusbio.in. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Nucleus Biosciences is at 64 Shri Harikrupa Ind Park Ring Road Hathijan, Ahmedabad, Gujarat, India – 382445.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages